Volume 86, issue 4, Avril 1999

Articles originaux

Mutation by deletion-insertion in BRCA-1 gene in three unrelated French breast/ovarian cancer families: possible implication of a mobile element (p.385-90)
Nadège Presneau, Valérie Laplace-Marieze, Valérie Sylvain, Alain Lortholary, Agnès Hardouin, Dominique Bernard-Gallon, Yves-Jean Bignon

High dose chemotherapy with autologous stem cell support in the treatment of germ cell tumors: experience of the centre Léon-Bérard between 1982 and 1996 (p.391-9)
Aude Fléchon, Pierre Biron, Irène Philip, Jean-Yves Blay, Jean-Pierre Droz

Synthèses

Cell cycle regulation after exposure to ionizing radiation (p.345-57)
Franck Teyssier, Jacques-Olivier Bay, Claude Dionet, Pierre Verrelle

Mechanisms of BTG2 activity, a transcriptional target of p53: evidences and hypothesis (p.358-63)
Alain Puisieux, Jean-Pierre Magaud

Point sur…

BAY-12-9566 (p.337-9)
Amélie Lansiaux, Jean-Pierre Hénichart, Christian Bailly

Méthodologie

Usefulness of a pharmacokinetic approach for clinical antineoplastic chemotherapy evaluation (p.341-4)
François Lokiec

Standards, Options et Recommandations

Standards, Options and Recommendations (SOR) for clinical care of malignant thymoma (p.365-84)
Groupe de travail SOR : Pierre Ruffié, Guillaume Gory-Delabaere, Béatrice Fervers, Michel Lehmann, Jean-François Regnard, Michel Resbeut